Mark Edbrooke, PhD is an independent scientific consultant, who brings broad experience in pharmaceutical research and development. During his 25 year tenure at GlaxoSmithKline, he ran a transnational functional genomics department, and then set up and led GSK’s therapeutic oligonucleotide unit. He then joined AstraZeneca’s Oncology Division for 3 years, working with Moderna and others. He currently has a portfolio of clients including UK- and European-based universities, UK- and US-based investment companies, and small biotechs across the globe including being Head of Translational Research at Argonaute RNA Ltd., and on the SAB for Deep Genomics.